SPHERA FUNDS MANAGEMENT LTD. - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2016$1,840,000
-48.3%
400,000
-41.6%
0.40%
-23.6%
Q4 2015$3,562,000
+0.8%
685,000
+17.3%
0.52%
+15.7%
Q3 2015$3,534,000
+8.4%
584,089
+182.9%
0.45%
+41.4%
Q2 2015$3,261,000206,5000.32%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q2 2015
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders